dr. Karin Weening

Journal Article
A1
open access

Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trials

Joline Ingels (UGent) , Laurenz De Cock (UGent) , Rupert Mayer (UGent) , Pam Devreker (UGent) , Karin Weening (UGent) , Kelly Heyns (UGent) , Nele Lootens (UGent) , Saskia De Smet (UGent) , Marieke Brusseel (UGent) , Stijn De Munter (UGent) , et al.

(2022) CYTOTHERAPY. 24(2). p.213-222

Add to list

Journal Article
A1
open access

In vitro OP9-DL1 co-culture and subsequent maturation in the presence of IL-21 generates tumor antigen-specific T cells with a favorable less-differentiated phenotype and enhanced functionality

Sarah Bonte (UGent) , Stijn De Munter (UGent) , Lore Billiet (UGent) , Glenn Goetgeluk (UGent) , Joline Ingels (UGent) , Hanne Jansen (UGent) , Melissa Pille (UGent) , Laurenz De Cock (UGent) , Karin Weening (UGent) , Tom Taghon (UGent) , et al.

(2021) ONCOIMMUNOLOGY. 10(1).

Add to list

Journal Article
A1
open access

Human thymic CD10+ PD-1+ intraepithelial lymphocyte precursors acquire interleukin-15 responsiveness at the CD1a– CD95+ CD28– CCR7– developmental stage

Lore Billiet (UGent) , Glenn Goetgeluk (UGent) , Sarah Bonte (UGent) , Stijn De Munter (UGent) , Laurenz De Cock (UGent) , Melissa Pille (UGent) , Joline Ingels (UGent) , Hanne Jansen (UGent) , Karin Weening (UGent) , Filip Van Nieuwerburgh (UGent) , et al.

(2020) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 21(22).

Add to list

Journal Article
A1
open access

The human fetal thymus generates invariant effector γδ T cells

Paola Tieppo, Maria Papadopoulou, Deborah Gatti, Naomi McGovern, Jerry K. Y. Chan, Francoise Gosselin, Glenn Goetgeluk (UGent) , Karin Weening (UGent) , Ling Ma, Nicolas Dauby, et al.

(2020) JOURNAL OF EXPERIMENTAL MEDICINE. 217(3).

Add to list

Journal Article
A1
open access

Rapid and effective generation of nanobody based CARs using PCR and Gibson Assembly

Stijn De Munter (UGent) , Alexander Van Parys (UGent) , Layla Bral, Joline Ingels (UGent) , Glenn Goetgeluk (UGent) , Sarah Bonte (UGent) , Melissa Pille (UGent) , Lore Billiet (UGent) , Karin Weening (UGent) , Annick Verhee (UGent) , et al.

(2020) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 21(3).

Add to list

Distinct Notch1 and BCL11B requirements mediate human γδ/αβ T cell development

Anne-Catherine Dolens, Kaat Durinck (UGent) , Marieke Lavaert, Joni Van der Meulen (UGent) , Imke Velghe (UGent) , Jelle De Medts (UGent) , Karin Weening (UGent) , Juliette Roels (UGent) , Katrien De Mulder (UGent) , Pieter-Jan Volders (UGent) , et al.

(2020) EMBO REPORTS. 21(5).

Add to list

Journal Article
A1
open access

TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment

Barbara Depreter, Karin Weening (UGent) , Karl Vandepoele (UGent) , Magnus Essand, Barbara De Moerloose (UGent) , Maria Themeli, Jacqueline Cloos, Diana Hanekamp, Ine Moors (UGent) , Inge D'hont (UGent) , et al.

(2020) HAEMATOLOGICA. 105(5). p.1306-1316

Add to list

Conference Paper
C3
open access

TARP as immunotherapeutic target in AML expressed in the LSC compartment

Barbara Depreter, Karin Weening (UGent) , Karl Vandepoele (UGent) , M Essand, Barbara De Moerloose (UGent) , M Themeli, J Cloos, D Hanekamp, Ine Moors (UGent) , Inge D'hont (UGent) , et al.

(2019) HEMASPHERE. 3(suppl. 1). p.54-54

Add to list

Journal Article
A1
open access

Nanobody based dual specific CARs

Stijn De Munter (UGent) , Joline Ingels (UGent) , Glenn Goetgeluk (UGent) , Sarah Bonte (UGent) , Melissa Pille (UGent) , Karin Weening (UGent) , Tessa Kerre (UGent) , Hinrich Abken and Bart Vandekerckhove (UGent)

(2018) INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 19(2).

Add to list

A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo

Isabelle Desombere (UGent) , Ahmed Atef Ahmed Abouzeid Mesalam (UGent) , Richard A Urbanowicz, Freya Van Houtte (UGent) , Lieven Verhoye (UGent) , Zhen-Yong Keck, Aliasghar Farhoudi Moghadam (UGent) , Koen Vercauteren, Karin Weening (UGent) , Thomas F Baumert, et al.

(2017) ANTIVIRAL RESEARCH. 148. p.53-64

Academic Bibliography

dr. Karin Weening

Small-scale manufacturing of neoantigen-encoding messenger RNA for early-phase clinical trials

In vitro OP9-DL1 co-culture and subsequent maturation in the presence of IL-21 generates tumor antigen-specific T cells with a favorable less-differentiated phenotype and enhanced functionality

Human thymic CD10+ PD-1+ intraepithelial lymphocyte precursors acquire interleukin-15 responsiveness at the CD1a– CD95+ CD28– CCR7– developmental stage

The human fetal thymus generates invariant effector γδ T cells

Rapid and effective generation of nanobody based CARs using PCR and Gibson Assembly

Distinct Notch1 and BCL11B requirements mediate human γδ/αβ T cell development

TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment

TARP as immunotherapeutic target in AML expressed in the LSC compartment

Nanobody based dual specific CARs

A novel neutralizing human monoclonal antibody broadly abrogates hepatitis C virus infection in vitro and in vivo

Contents

Support

Contact